Most recent by Jesal Haribhakti, OD, FAAO
GLP-1RA use linked to 19% reduction in risk for glaucoma in type 2 diabetes
Use of glucagon-like peptide-1 receptor agonists was associated with a 19% reduction in risk for glaucoma in patients with type 2 diabetes, with longer use extending the protective association, according to a study in Ophthalmology.
Six biomarkers predict AMD progression with greater certainty than ‘large drusen’ sign
Researchers have identified biomarkers that predict age-related macular degeneration progression as well as biomarkers associated with progression to geographic atrophy and neovascularization, according to a review published in Ophthalmology Retina.
Adherence to Mediterranean diet may decrease risk for AMD progression
A high intake of specific nutrients, antioxidant supplementation and adherence to the Mediterranean diet may decrease the progression of age-related macular degeneration, according to a review in Acta Ophthalmologica.
COVID-19, delayed treatments contribute to ocular issues
The COVID-19 virus created several complications for patients within the systemic and ocular health care systems, including increased ocular manifestations and delayed treatments, according to a review in Clinical Ophthalmology.